Icon PLC (ICLR): EPS (Diluted)
$2.90
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.90 | -67.4% | 2026-05-27, From 2025-01-01 |
| 2024-12-31 | $8.90 | +32.8% | 2026-05-27, From 2024-01-01 |
| 2023-12-31 | $6.70 | n/c | 2026-05-27, From 2023-01-01 |
| 2022-12-31 | $6.13 | +172.4% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $2.25 | -63.4% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $6.15 | -9.4% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $6.79 | +15.3% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $5.89 | +14.8% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $5.13 | +10.3% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $4.65 | +17.1% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $3.97 | +45.4% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $2.73 | +65.5% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $1.65 | +79.3% | 2016-03-23, From 2013-01-01 |
| 2012-12-31 | $0.92 | +148.6% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $0.37 | -74.3% | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | $1.44 | -8.3% | 2013-03-06, From 2010-01-01 |
| 2009-12-31 | $1.57 | +20.8% | 2012-03-02, From 2009-01-01 |
| 2008-12-31 | $1.30 | n/a | 2011-03-22, From 2008-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $2.90 | -67.4% |
| Incyte Corp (INCY) | 2025-12-31 | $6.41 | n/m |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $7.84 | +4.7% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | -$2.91 | n/m |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $15.28 | +21.0% |
| NRC Health (NRC) | 2025-12-31 | $50.00 | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$0.42 | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$0.57 | n/m |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | -$8.66 | n/m |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗